A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain

por Ziegler, Dan, Duan, W. Rachel, An, Guohua, Thomas, James W., Nothaft, Wolfram
Publicado 2015

Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn’s Disease: Results from the Phase 2 Open-Label Extension Study

por Ferrante, Marc, Feagan, Brian G, Panés, Julián, Baert, Filip, Louis, Edouard, Dewit, Olivier, Kaser, Arthur, Duan, W Rachel, Pang, Yinuo, Lee, Wan-Ju, Gustafson, Dawn, Liao, Xiaomei, Wallace, Kori, Kalabic, Jasmina, D’Haens, Geert R
Publicado 2021